l9n/ New Jersey

2024–2025 Session

Assembly Bill 4628

Requires health benefits coverage of continuous glucose monitoring system for treatment of glycogen storage disease.

Did not become law. It stopped in the Senate on January 12, 2026. The 2024–2025 session has ended.

Sponsors

Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.

In the General Assembly

2 co-sponsors

Cody D. Miller, Michael Venezia

Its course

June 25, 2024 to January 12, 2026, on one scale. In the top row each mark is a day something happened; taller marks are busier days.

Each committee stop sits inside its chamber.

Every action4 actions on 4 days

In the General AssemblyJun 25 to Jan 12566 days

Financial Institutions and InsuranceJun 25 to Dec 11534 days

AppropriationsDec 11 to Jan 828 days

In the SenateJan 12 to Jan 12 · stopped0 days

Votes

Yeas to nays, as the Legislature recorded them. Committee votes are set in.

  • General Assembly, third reading70–0

    Passed · Jan 12, 2026 · 5 present

Text

Each version as the Legislature printed it.

l9n doesn't hold this bill's text yet.

What happened

In l9n's words, one line for each step. Every action as the Legislature published it is below.

In the General Assembly Jun 25 – Jan 12, 2026

  1. Introduced in the General Assembly and sent to Financial Institutions and Insurance
  2. Financial Institutions and Insurance recommended it
  3. Sent to Appropriations
  4. Appropriations recommended it
  5. Read a second time
  6. Passed the General Assembly, 70 to 0
All 4 actions, as published